Literature DB >> 17387238

Intact germinal layer of liver hydatid cysts removed after administration of albendazole.

A Manouras1, M Genetzakis, E E Lagoudianakis, A Papadima, C Triantafillou, P V Kekis, K Filis, V Katergiannakis.   

Abstract

BACKGROUND: Hydatid disease is a common health problem especially in Mediterranean and sheep-farming countries, caused by infection with the metacestode stage of the tapeworm Echinococcus. The liver is the most frequent primary site of Echinococcus granulosus infection in humans. Surgery remains the main treatment modality for cystic hepatic hydatid disease, with complete resection of the germinal layer being of major importance for recurrence. Perioperative administration of albendazole has been reported to improve surgical outcome but the results are controversial. We report here our observations on the usefulness of preoperative chemotherapy in surgical outcome in terms of morbidity and recurrence.
METHODS: Five patients with complex liver hydatid cysts received 28 days of albendazole prior to partial cystectomy. Radiological examinations with computed tomography and ultrasound and surgical outcome were used to assess the efficacy of the regimen.
RESULTS: Three patients underwent a complete removal of the germinal layer of the cyst and there were no cases of biliary fistula in these patients. There were no relapses in any of the patients at 12 months' follow-up.
CONCLUSIONS: Preoperative use of medical therapy consisting of albendazole facilitates complete resection of the germinal layer by detaching it from the laminar layer, thus reducing not only the recurrence rates but also the postoperative complications, especially bilious fistulas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17387238

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  7 in total

1.  Ultrastructural changes in hydatid cyst walls obtained from human cases, exposed to different therapeutic approaches.

Authors:  Hoda Abdel Aziz Al Shinawy Shaheen; Saedia Abdel Hady Sayed El-Ahl; Amr Mahmoud Abdel Raouf; Marwa Ahmed El-Dardiry; Manal A Badawi; Amany Ahmed Abdel Aal
Journal:  Parasitol Res       Date:  2019-10-02       Impact factor: 2.289

2.  Non-spinal Hydatid Disease of Bone: A Series of Nine Cases.

Authors:  Khodamorad Jamshidi; Farshad Zandrahimi; Milad Haji Agha Bozorgi; Seyed Farzam Mirkamali; Abbas Esmaeli Dahaj; Alireza Mirzaei
Journal:  Arch Bone Jt Surg       Date:  2022-05

3.  Laparoscopic upper pole splenectomy of the simple splenic cyst.

Authors:  David João Silva Aparício; Carlos Leichsenring; Ângela Reis Rodrigues; Ana Catarina Alves
Journal:  BMJ Case Rep       Date:  2013-11-28

4.  Endocystectomy as a conservative surgical treatment for hepatic cystic echinococcosis: A systematic review with single-arm meta-analysis.

Authors:  Mohammad Al-Saeedi; Ali Ramouz; Elias Khajeh; Ahmad El Rafidi; Omid Ghamarnejad; Saeed Shafiei; Sadeq Ali-Hasan-Al-Saegh; Pascal Probst; Marija Stojkovic; Tim Frederik Weber; Katrin Hoffmann; Arianeb Mehrabi
Journal:  PLoS Negl Trop Dis       Date:  2021-05-12

5.  Evaluation of the efficacy of Zataria multiflora essential oil versus albendazole in patients infected with liver cystic echinococcosis: A nonrandomized clinical trial.

Authors:  Arash Jafari; Mohammad Moazeni; Seyed Vahid Hosseini; Hajar Khazraei; Saeedeh Pourahmad
Journal:  J Res Med Sci       Date:  2021-12-22       Impact factor: 1.852

6.  The Effect of Preoperative Albendazole Treatment on Intramuscular Cyst Structure in a Patient with Simultaneous Cystic Echinococcusis of Liver and Vastus Lateralis Muscle.

Authors:  Mahmut Kursat Ozsahin; Bedri Karaismailoglu; Cumhur Deniz Davulcu; Erdem Sahin; Murat Hız
Journal:  Iran J Parasitol       Date:  2022 Jan-Mar       Impact factor: 1.217

7.  Gamma-Ray Treatment of Echinococcus Protoscoleces prior to Implantation in Mice Reduces Echinococcosis.

Authors:  Qing Yuan; Bo Li; Shiping Jiang; Qiang Zhao; Ji Duo; Xiang Huang
Journal:  Biomed Res Int       Date:  2016-08-16       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.